Cargando…

Reduced gastric acidity, proton pump inhibitors and increased severity of COVID-19 infections

Detalles Bibliográficos
Autores principales:	Price, Elizabeth, Treacher, David F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891478/ https://www.ncbi.nlm.nih.gov/pubmed/33602257 http://dx.doi.org/10.1186/s13054-021-03497-6

Ejemplares similares

Could the severity of COVID-19 be increased by low gastric acidity?
por: Price, Elizabeth
Publicado: (2020)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

COVID-19 Mortality: The Culprit May Not Be Proton Pump Inhibitors
por: Duan, Zhihui, et al.
Publicado: (2022)

Proton pump inhibitors increase risk of COVID-19
Publicado: (2020)

Proton Pump Inhibitor Induced Depigmentation in Vitiligo
por: Holla, Anantha Prasad, et al.
Publicado: (2011)

Increased Proton Pump Inhibitors−Induced Mortality Risk in Hemodialysis Patients
por: Sertorio, Jonas T., et al.
Publicado: (2018)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19
por: Homolak, Jan, et al.
Publicado: (2021)

Is hypomagnesemia associated with using proton pump inhibitors?
por: Yi, Joo-Hark, et al.
Publicado: (2016)

Proton pump inhibitors increase the severity of hepatic encephalopathy in cirrhotic patients
por: Fasullo, Matthew, et al.
Publicado: (2019)

802. Proton Pump Inhibitors Increase Clostridioides difficile Disease Severity Controlling for Infecting Strains
por: Fallatah, Saad, et al.
Publicado: (2020)

Gastric Epithelial Cell Modality and Proton Pump Inhibitor
por: Masaoka, Tatsuhiro, et al.
Publicado: (2008)

Proton pump inhibitor: The dual role in gastric cancer
por: Joo, Moon Kyung, et al.
Publicado: (2019)

Proton Pump Inhibitor-Related Gastric Mucosal Changes
por: Kim, Gwang Ha
Publicado: (2021)

Use of proton pump inhibitors for the risk of gastric cancer
por: Gao, Huiqin, et al.
Publicado: (2022)

Rutin exerts antiulcer effect by inhibiting the gastric proton pump
por: Dubey, Shagun, et al.
Publicado: (2013)

What is the role of proton pump inhibitors consumption on the clinical presentation and severity of COVID-19 infection?
por: Shokri, M.A., et al.
Publicado: (2023)

Proton-pump inhibitors should be strictly prescribed in clinic
por: Yang, Xuesong, et al.
Publicado: (2022)

Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2020)

Can Nocturnal Acid-breakthrough Be Reduced by Long-acting Proton Pump Inhibitors?
por: Jeon, Hye Kyung, et al.
Publicado: (2017)

Proton pump inhibitors in the COVID-19 pandemic()
por: Sebastián Domingo, Juan J.
Publicado: (2021)

Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness
por: Brett, Stephen
Publicado: (2005)

Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?
por: Tomita, Toshihiko, et al.
Publicado: (2011)

Can proton pump inhibitors reduce rebleeding following Histoacryl sclerotherapy for gastric variceal hemorrhage?
por: Kim, Ka Rham, et al.
Publicado: (2015)

Proton-Pump Inhibitors and Fragility Fractures in Vulnerable Older Patients
por: Zirk-Sadowski, Jan, et al.
Publicado: (2017)

Deprescribing in older people: helpful tools and proton pump inhibitors
Publicado: (2020)

Exploration of Proton Pump Inhibitors Use During Pregnancy and Preeclampsia
por: Choi, Ahhyung, et al.
Publicado: (2021)

Prevalence of Proton Pump Inhibitor Use Among Patients With Cancer
por: Raoul, Jean-Luc, et al.
Publicado: (2021)

Effect of proton pump inhibitor use on Helicobacter pylori positivity and atrial fibrillation
por: Atay, Kadri, et al.
Publicado: (2015)

Impact of a Restriction in Reimbursement on Proton Pump Inhibitors in Patients with an Increased Risk of Gastric Complications
por: Flinterman, Linda E., et al.
Publicado: (2018)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Proton Pump Inhibitors Reduce the Size and Acidity of the Gastric Acid Pocket: (Clin Gastroenterol Hepatol 2014;12:1101–1107, e1)
por: Jo, Yunju
Publicado: (2015)

The costly case of proton-pump inhibitors: a single-center experience
por: Suresh Kumar, Vishnu Charan, et al.
Publicado: (2020)

Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19?
por: Charpiat, Bruno, et al.
Publicado: (2020)

Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?: Author's Reply
por: Nonaka, Takashi, et al.
Publicado: (2011)

Proton Pump Inhibitor Induction of Gastric Cobblestone-like Lesions in the Stomach
por: Takahari, Kosuke, et al.
Publicado: (2017)

Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids—What Is the Relationship?
por: McCarthy, Denis M.
Publicado: (2020)

The effect of proton pump inhibitors and vonoprazan on the development of ‘gastric mucosal redness’
por: Shinozaki, Satoshi, et al.
Publicado: (2022)

Association between proton pump inhibitors and periodontal disease severity
por: Chawla, Bhavneet K., et al.
Publicado: (2021)

Proton-pump inhibitor use amongst patients with severe hypomagnesemia
por: Seah, Sherry, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u82m6lk4n4k4tjjaem51rrmcke